🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will estimate how fast two antiepileptic drugs (Levetiracetam an...
Status
Completed
Location
Ep0074 001
Start Date
2015-11
Trial ID
NCT02602860
Treatments Being Tested
To evaluate if Brivaracetam (BRV) influences the psychomotor and cognitive ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01710670
Treatments Being Tested
N01372 study is to evaluate the long-term safety, tolerability, maintenance...
Status
Completed
Location
103
Start Date
2012-10
Trial ID
NCT01728077
Treatments Being Tested
This Compassionate Use Program (CUP) is setup to provide study patients wit...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03532516
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) ...
Status
Completed
Location
Ep0083 905
Start Date
2017-08-22
Trial ID
NCT03083665
Treatments Being Tested
The main purpose of this study is to see whether brivaracetam has a faster ...
Status
Completed
Location
The Comprehensive Epilepsy Care Center For Children And Adults
Start Date
2018-06-01
Trial ID
NCT03580707
Treatments Being Tested
This is a multicenter, open-label, 4-arm, randomized, parallel-group study ...
Status
Completed
Location
001
Start Date
2011-08
Trial ID
NCT01405508
Treatments Being Tested
The primary objective of this study is to compare the efficacy of Brivarace...
Status
Terminated
Location
3
Start Date
2014-03
Trial ID
NCT02088957
The purpose of the study is to assess the pharmacokinetics, safety, and tol...
Status
Completed
Location
Ep0101 101
Start Date
2021-05-19
Trial ID
NCT04882540
Treatments Being Tested
The purpose of this study is to assess the efficacy of intravenous brivarac...
Status
Completed
Location
Ep0087 108
Start Date
2017-02-06
Trial ID
NCT03021018
Treatments Being Tested